Executing with
balance and focus to deliver growth and create value
We are a global leader in Sample to Insight solutions, with a portfolio of technologies to empower customers from
start to finish in the molecular analysis process. In a challenging world, our approach is to help customers achieve
molecular insights faster, better and more efficiently.
Our strategy contains a focus on our growth pillars. In these areas we are aligning our investments to maximize sales in proven high-growth markets,
targeting at least $2 bn net sales (CER) from growth pillars in 2028. See the key product areas section on our products page for more details.
Across the globe, we serve over 500,000 customers (see our global presence page for more details). We have built a unique
competitive advantage for QIAGEN: Deep relationships with customers across the continuum from academic research, to
pharmaceutical development, to molecular diagnostics and other applications. We partner with researchers in creating
molecular testing technologies in the early stages, then develop and commercialize promising applications and
platforms as these methods emerge in healthcare and industry.